Afya (NASDAQ:AFYA) Cut to “Neutral” at UBS Group

UBS Group cut shares of Afya (NASDAQ:AFYA) from a buy rating to a neutral rating in a report published on Friday, Marketbeat Ratings reports. The firm currently has $16.00 price target on the stock.

A number of other equities analysts have also recently issued reports on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Afya from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 10th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $22.00 price target (down previously from $24.50) on shares of Afya in a report on Wednesday, January 7th. Zacks Research lowered shares of Afya from a “hold” rating to a “strong sell” rating in a report on Friday, January 9th. Finally, Sanford C. Bernstein raised Afya to a “market perform” rating in a research report on Friday. One equities research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $17.38.

Afya Stock Down 3.2%

Shares of NASDAQ:AFYA opened at $13.93 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.21. The stock has a fifty day simple moving average of $14.78 and a two-hundred day simple moving average of $15.00. Afya has a 12-month low of $13.12 and a 12-month high of $19.90. The stock has a market capitalization of $1.31 billion, a price-to-earnings ratio of 10.02, a PEG ratio of 0.52 and a beta of 0.53.

Hedge Funds Weigh In On Afya

A number of institutional investors and hedge funds have recently modified their holdings of AFYA. Goldman Sachs Group Inc. grew its holdings in shares of Afya by 167.3% in the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after acquiring an additional 28,226 shares during the period. Perpetual Ltd grew its stake in shares of Afya by 1.8% during the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock valued at $2,700,000 after purchasing an additional 2,730 shares during the period. R Squared Ltd purchased a new stake in shares of Afya during the 2nd quarter valued at about $264,000. Carrera Capital Advisors bought a new position in shares of Afya in the 2nd quarter worth approximately $1,750,000. Finally, Campbell & CO Investment Adviser LLC lifted its stake in shares of Afya by 31.5% in the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 51,340 shares of the company’s stock worth $917,000 after purchasing an additional 12,286 shares during the period. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.